I agree.... to me ARDS which has it's origins in the lungs - will give Ryoncil the highest chance of having the biggest effect, since the cells are IV administered and go directly there with many of them getting stuck in the lungs - even in the absence of ARDS.
GvHD was a much more complicated beast with the cells needing to migrate out of the blood stream into the gut area, skin etc and organs of the gut which sounds like a more challenging, time consuming task for them.
I would think a headline of - "powerful cure, extremely effective with no side effects, not approved because FDA does not understand how it works or how best to manufacture it"
I couldn't imagine that happening in any version of events for COVID where efficacy is shown.
- Forums
- ASX - By Stock
- MSB
- MSB - Most exciting 6 months
MSB - Most exciting 6 months, page-614
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B |
Open | High | Low | Value | Volume |
$1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 48074 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 1.780 |
3 | 33582 | 1.775 |
5 | 69873 | 1.770 |
1 | 40000 | 1.765 |
7 | 132755 | 1.760 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 47774 | 3 |
1.795 | 41537 | 3 |
1.800 | 67989 | 6 |
1.805 | 500 | 1 |
1.810 | 50764 | 4 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |